| Financial Year |
March 31 2023 |
| Monetary Funds |
2,948,871,363.67 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,042,988.86 |
| Accounts Receivable |
2,465,532,675.48 |
| Advances to Suppliers |
49,127,442.54 |
| Other Receivables |
104,191,018.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
262,844,598.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
35,115,035.52 |
| Other Current Assets |
167,613,966.30 |
| Total Current Assets |
6,656,304,568.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,951,994,152.76 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
10,146,467,679.47 |
| Under-construction Projects |
6,524,301,789.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,730,238,678.39 |
| R&D expenses |
-- |
| Goodwill |
1,866,108.25 |
| Long-Term Deferred and Prepaid Expenses |
51,844,522.28 |
| Deferred Income Tax Assets |
224,332,881.67 |
| Other Non-Current Assets |
1,575,103,058.55 |
| Sub-Total of Non-Current Assets |
32,253,357,528.32 |
| Total Assets |
38,909,662,096.77 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
101,577,632.52 |
| Accounts Payable |
5,200,469,935.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
143,230,042.03 |
| Taxes Payable |
125,239,449.27 |
| Interest Payable |
-- |
| Dividend Payable |
485,675.06 |
| Other payables |
996,799,017.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
607,165,572.81 |
| Other Current Liabilities |
141,629,398.28 |
| Sub-Total of Current Liabilities |
7,819,581,959.20 |
| Long-term Loans |
6,166,419,044.77 |
| Bonds Payable |
3,949,653,124.36 |
| Long-Term Accounts Payable |
3,822,348,176.50 |
| Special Payable |
-- |
| Estimatied Liabilities |
697,552,918.33 |
| Deferred Income Tax Liabilities |
45,704,842.18 |
| Other Non-Current Liabilities |
108,000,766.96 |
| Sub-Total of Non-Current Liabilities |
14,924,808,484.50 |
| Total Liabilities |
22,744,390,443.70 |
| Paid-In Capital(Or Share Stock) |
2,985,566,321.00 |
| Capital Surplus |
1,780,807,636.38 |
| Surplus Reserve |
558,084,429.04 |
| LESS:Treasury Stock |
73,522,068.04 |
| Undistributed Profits |
9,900,607,482.07 |
| Minority Stockholder's Interest |
1,003,731,758.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
15,161,539,894.75 |
| Owner's Equity（Stockholder's Equity） |
16,165,271,653.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
38,909,662,096.77 |
